BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19747564)

  • 1. Individual domains of Tensin2 exhibit distinct subcellular localisations and migratory effects.
    Hafizi S; Sernstad E; Swinny JD; Gomez MF; Dahlbäck B
    Int J Biochem Cell Biol; 2010 Jan; 42(1):52-61. PubMed ID: 19747564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tensin1 and a previously undocumented family member, tensin2, positively regulate cell migration.
    Chen H; Duncan IC; Bozorgchami H; Lo SH
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):733-8. PubMed ID: 11792844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solution structure of tensin2 SH2 domain and its phosphotyrosine-independent interaction with DLC-1.
    Dai K; Liao S; Zhang J; Zhang X; Tu X
    PLoS One; 2011; 6(7):e21965. PubMed ID: 21765928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solution structure of the phosphotyrosine binding (PTB) domain of human tensin2 protein in complex with deleted in liver cancer 1 (DLC1) peptide reveals a novel peptide binding mode.
    Chen L; Liu C; Ko FC; Xu N; Ng IO; Yam JW; Zhu G
    J Biol Chem; 2012 Jul; 287(31):26104-14. PubMed ID: 22645138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tensin2 reduces intracellular phosphatidylinositol 3,4,5-trisphosphate levels at the plasma membrane.
    Hafizi S; Gustafsson A; Oslakovic C; Idevall-Hagren O; Tengholm A; Sperandio O; Villoutreix BO; Dahlbäck B
    Biochem Biophys Res Commun; 2010 Aug; 399(3):396-401. PubMed ID: 20678486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression.
    Yam JW; Ko FC; Chan CY; Jin DY; Ng IO
    Cancer Res; 2006 Sep; 66(17):8367-72. PubMed ID: 16951145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deleted in liver cancer 1 (DLC1) utilizes a novel binding site for Tensin2 PTB domain interaction and is required for tumor-suppressive function.
    Chan LK; Ko FC; Ng IO; Yam JW
    PLoS One; 2009; 4(5):e5572. PubMed ID: 19440389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. START-GAP1/DLC1 is localized in focal adhesions through interaction with the PTB domain of tensin2.
    Kawai K; Kitamura SY; Maehira K; Seike J; Yagisawa H
    Adv Enzyme Regul; 2010; 50(1):202-15. PubMed ID: 19895840
    [No Abstract]   [Full Text] [Related]  

  • 9. 1H, 15N and 13C chemical shift assignments of the SH2 domain of human tensin2 (TENC1).
    Chen L; Liu C; Rui F; Zhu G
    Biomol NMR Assign; 2011 Oct; 5(2):211-4. PubMed ID: 21461930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protein-tyrosine kinase Syk interacts with the C-terminal region of tensin2.
    Moon KD; Zhang X; Zhou Q; Geahlen RL
    Biochim Biophys Acta; 2012 Feb; 1823(2):199-205. PubMed ID: 22019427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of DISC1 with the PTB domain of Tensin2.
    Goudarzi S; Smith LJ; Schütz S; Hafizi S
    Cell Mol Life Sci; 2013 May; 70(9):1663-72. PubMed ID: 23233134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tensin2 variant 3 is associated with aggressive tumor behavior in human hepatocellular carcinoma.
    Yam JW; Ko FC; Chan CY; Yau TO; Tung EK; Leung TH; Jin DY; Ng IO
    Hepatology; 2006 Oct; 44(4):881-90. PubMed ID: 17006924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1.
    Liao YC; Si L; deVere White RW; Lo SH
    J Cell Biol; 2007 Jan; 176(1):43-9. PubMed ID: 17190795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities.
    Qian X; Li G; Asmussen HK; Asnaghi L; Vass WC; Braverman R; Yamada KM; Popescu NC; Papageorge AG; Lowy DR
    Proc Natl Acad Sci U S A; 2007 May; 104(21):9012-7. PubMed ID: 17517630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular phosphatase activity of C1-Ten/Tensin2 is controlled by Phosphatidylinositol-3,4,5-triphosphate binding through the C1-Ten/Tensin2 SH2 domain.
    Kim E; Kim DH; Singaram I; Jeong H; Koh A; Lee J; Cho W; Ryu SH
    Cell Signal; 2018 Nov; 51():130-138. PubMed ID: 30092354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of Axl receptor tyrosine kinase with C1-TEN, a novel C1 domain-containing protein with homology to tensin.
    Hafizi S; Alindri F; Karlsson R; Dahlbäck B
    Biochem Biophys Res Commun; 2002 Dec; 299(5):793-800. PubMed ID: 12470648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tensin.
    Lo SH
    Int J Biochem Cell Biol; 2004 Jan; 36(1):31-4. PubMed ID: 14592531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tensin2 is a novel mediator in thrombopoietin (TPO)-induced cellular proliferation by promoting Akt signaling.
    Jung AS; Kaushansky A; Macbeath G; Kaushansky K
    Cell Cycle; 2011 Jun; 10(11):1838-44. PubMed ID: 21527831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tensin1 requires protein phosphatase-1alpha in addition to RhoGAP DLC-1 to control cell polarization, migration, and invasion.
    Hall EH; Daugherty AE; Choi CK; Horwitz AF; Brautigan DL
    J Biol Chem; 2009 Dec; 284(50):34713-22. PubMed ID: 19826001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of C1-Ten protein tyrosine phosphatase by p62/SQSTM1-mediated sequestration and degradation.
    Koh A; Park D; Jeong H; Lee J; Lee MN; Suh PG; Ryu SH
    Cell Signal; 2014 Nov; 26(11):2470-80. PubMed ID: 25101860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.